Vinge has advised Röko AB (publ) (“Röko”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on March 4, 2025 and the first day of trading is March 11, 2025.

The offering price was SEK 2,048 per class B share, corresponding to a total market value for all shares in Röko of approximately SEK 29.95 billion. The total value of the offering amounts to approximately SEK 5,284 million.

Röko is a Sweden-based serial acquirer that has completed 28 platform acquisitions in a variety of industries across Europe. The company's ambition is to be the perpetual owner of small and medium-sized businesses. Historically, Röko has primarily acquired small and medium-sized businesses headquartered in the Nordics and Northern Europe. Röko's organization has more than 100 years of combined experience working with founder- and entrepreneur-led companies in a wide range of industries and the individuals in executive management positions have worked at the company since its first year of operation.

Vinge’s team primarily consisted of Linnéa Sellström, Jesper Schönbeck, Erik Sjöman, Lorin Arabi, Annie Fällström, Michaela Ådén, Karin Karsten, Louise Nässén and Lovisa Jonassen (Capital Markets and Public M&A), Victor EricssonEmelie Svanberg, Erik Kochbati, Marcus Svärd and Ellenor Eckerborn (Corporate Tax), Helena Göransson, Nour Makie and William Carlberg Johansson (Financing), Nicklas Thorgerzon, Martin Boström and Elis Allmark (Commercial agreements, IT and GDPR) Johan Gavelin (Intellectual Property), Gulestan Ali (Regulatory) as well as Louisa Fagarasan (Employment).

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025